McKesson Agrees To Settle AWP Case For $350M
private-party litigation alleging the pharmaceutical distributor conspired to raise the average wholesale price for thousands of drugs.
The $350 million settlement announced by the company Friday will now be submitted to the court for preliminary approval. Afterward, notices will be sent to the class, and a final approval hearing will be held, both the company and the plaintiffs' counsel noted, predicting that a final approval hearing would be set sometime this summer.
While McKesson has...
To view the full article, register now.